https://www.live-feeds.com/feed/boston-sci-slammed-after-cyberattack-hamstrings-salesContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/boston-sci-slammed-after-cyberattack-hamstrings-saleshttps://www.live-feeds.com/feed/boston-sci-slammed-after-cyberattack-hamstrings-sales#u64502Fri, 11 Sep 2026 00:50:19 +0000Boston Scientific will likely miss its 2026 sales and profit guidance after a cyberattack disrupted operations. The company indicated it is unlikely to meet its earnings forecasts, leading to a drop in stock price. The attack hampered sales capabilities, forcing the medical device firm to revise its financial expectations for the year. Multiple financial news outlets confirm the company's inability to reach previously stated targets due to the security breach.Why it mattersFinancial guidance serves as a benchmark for investor expectations and company health. A failure to meet these foreca